← Browse by Condition
Medical Condition
vulvar lichen sclerosus
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for vulvar lichen sclerosus sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 1
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07352917 Phase 2
Recruiting
Methotrexate for Severe Vulvar Lichen Sclerosus
Enrollment
12 pts
Location
Brazil
Sponsor
Clinica Dermatologica Arbache ...
NCT06662942 Phase 1
Recruiting
StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms
Enrollment
100 pts
Location
United States
Sponsor
Andrew T. Goldstein, MD
NCT07240519
Recruiting
To Compare Inflammatory Biomarkers Before and After Treatment With Clobetasol or Fractional CO2 Laser, in Women With Histologically Confirmed Vulvar Lichen Sclerosus, Without Prior Corticosteroid Treatment.
Enrollment
40 pts
Location
Brazil
Sponsor
Universidade Federal do Rio de...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology